120 related articles for article (PubMed ID: 24130991)
21. Function of hemopoietic stem cells under conditions of cytostatic myelosuppression and treatment with hemostimilators.
Zhdanov VV; Gur'yantseva LA; Udut EV; Khrichkova TY; Simanina EV; Gol'dberg VE
Bull Exp Biol Med; 2005 Nov; 140(5):631-4. PubMed ID: 16758642
[TBL] [Abstract][Full Text] [Related]
22. Mechanisms of protective effect of Dicarbamin on the blood system in cytostatic treatment.
Nebolsin VE; Zhdanov VV; Zyuzkov GN; Udut EV; Khrichkova TY; Simanina EV; Stavrova LA; Miroshnichenko LA; Chaikovskiy AV; Dygai AM
Bull Exp Biol Med; 2011 Jan; 150(3):343-7. PubMed ID: 21240350
[TBL] [Abstract][Full Text] [Related]
23. Monoaminergic regulation of hemopoiesis under extreme conditions.
Dygai AM; Skurikhin EG
Bull Exp Biol Med; 2011 Jun; 151(2):171-8. PubMed ID: 22238743
[TBL] [Abstract][Full Text] [Related]
24. Adrenergic regulation of erythropoiesis during cytostatic-induced myelosuppressions.
Skurikhin EG; Pershina OV; Minakova MY; Ermakova NN; Firsova TV; Dygai AM; Gol'dberg ED
Bull Exp Biol Med; 2008 Oct; 146(4):405-10. PubMed ID: 19489307
[TBL] [Abstract][Full Text] [Related]
25. Effects and mechanisms of hemopoiesis-stimulating activity of immobilized oligonucleotides under conditions of cytostatic myelosuppression.
Dygai AM; Goldberg VE; Artamonov AV; Bekarev AA; Vereschagin EI; Madonov PG; Skurikhin EG; Pershina OV; Andreeva TV; Khmelevskaya ES; Ermakova NN
Bull Exp Biol Med; 2012 Feb; 152(4):451-5. PubMed ID: 22803109
[TBL] [Abstract][Full Text] [Related]
26. Involvement of Signaling Cascades in Granulocytopoiesis Regulation under Conditions of Cytostatic Treatment.
Zhdanov VV; Miroshnichenko LA; Zyuz'kov GN; Udut EV; Polyakova TY; Simanina EV; Sherstoboev EY; Stavrova LA; Agafonov VI; Minakova MY; Chaikovskii AV; Dygai AM
Bull Exp Biol Med; 2020 Aug; 169(4):426-430. PubMed ID: 32889566
[TBL] [Abstract][Full Text] [Related]
27. Role of serotonin in the regulation of granulocytopoiesis during cytostatic-induced myelosuppressions.
Skurikhin EG; Pershina OV; Minakova MY; Dygai AM; Gol'dberg ED
Bull Exp Biol Med; 2007 May; 143(5):569-74. PubMed ID: 18239769
[TBL] [Abstract][Full Text] [Related]
28. Effect of immobilized granulocyte colony-stimulating factor on hemopoietic precursors of various classes during cytostatic-induced myelosuppression.
Dygai AM; Skurikhin EG; Andreeva TV; Madonov PG; Vereshagin EI; Kinsht DN; Pershina OV; Khmelevskaya ES
Bull Exp Biol Med; 2010 Sep; 149(3):284-8. PubMed ID: 21246083
[TBL] [Abstract][Full Text] [Related]
29. [Role of the bone marrow lymphoid reaction in restoring hemopoiesis in suppression by cytostatic preparations].
Melik-Gaĭkazian EV
Probl Gematol Pereliv Krovi; 1980 Aug; 25(8):48-50. PubMed ID: 7413626
[No Abstract] [Full Text] [Related]
30. Neurosis-associated changes in the granulocytic hemopoietic stem in mice with different learning capacity.
Skurikhin EG; Pershina OV; Stavrova LA; Suslov NI; Minakova MY; Dygai AM; Gol'dberg ED
Bull Exp Biol Med; 2005 Aug; 140(2):171-6. PubMed ID: 16282993
[TBL] [Abstract][Full Text] [Related]
31. Role of NF-κB-dependent signaling and p38 MAPK signaling pathway in the control of hemopoiesis during cytostatic administration.
Dygai AM; Zhdanov VV; Zyuz'kov GN; Udut EV; Miroshnichenko LA; Simanina EV; Chaikovskii AV; Stavrova LA; Danilets MG
Bull Exp Biol Med; 2014 May; 157(1):32-6. PubMed ID: 24915945
[TBL] [Abstract][Full Text] [Related]
32. [The principles for creating drug preparations of natural origin that stimulate hematopoiesis].
Gol'dberg ED; Dygaĭ AM; Agafonov VI; Aksinenko SG; Gol'dberg VE; Zhdanov VV; Litvinenko VI; Liubavina PA; Matiash MG; Novitskiĭ EV
Eksp Klin Farmakol; 1995; 58(1):3-7. PubMed ID: 7787691
[TBL] [Abstract][Full Text] [Related]
33. [The role of the hemopoiesis-inducing microenvironment in the mechanisms of the regeneration of hemopoiesis after cytostatic exposure].
Dygaĭ AM; Zhadanov VV; Bogdashin IV; Gol'dberg VE
Nauchnye Doki Vyss Shkoly Biol Nauki; 1992; (9):109-16. PubMed ID: 1302526
[TBL] [Abstract][Full Text] [Related]
34. [Regulating effect of the hematopoiesis-inducing microenvironment on hematopoietic processes as affected by cytostatic drugs].
Dygaĭ AM; Zhdanov VV; Khlusov IA; Liubavina PA; Gol'dberg ED
Gematol Transfuziol; 1995; 40(5):11-5. PubMed ID: 8566652
[TBL] [Abstract][Full Text] [Related]
35. Role of stromal and Thy 1,2+ cells in the mechanisms of action of immobilized granulocyte colony-stimulating factor during cytostatic-induced myelosuppression.
Andreeva TV; Artamonov AV; Bekarev AA; Vereschagin EI; Madonov PG; Pershina OV; Skurikhin EG; Khmelevskaya ES; Dygai AM
Bull Exp Biol Med; 2011 Mar; 150(5):594-8. PubMed ID: 22235393
[TBL] [Abstract][Full Text] [Related]
36. Hemostimualting properties of preparation containing ultralow doses of antibodies to stem cell factor in cytostatic myelosuppression.
Stavrova LA; Zyuz'kov GN; Simanina EV; Miroshnichenko LA; Udut EV; Khrichkova TY; Skurikhin EG; Pershina OV; Ermakova NN; Firsova TV; Zhdanov VV; Dygai AM; Gol'dberg ED
Bull Exp Biol Med; 2009 Sep; 148(3):556-9. PubMed ID: 20396740
[TBL] [Abstract][Full Text] [Related]
37. Pharmacological properties of granulocytic colony-stimulating factor pegylated using electron beam synthesis nanotechnologies.
Dygai AM; Zyuz'kov GN; Zhdanov VV; Madonov PG; Udut EV; Miroshnichenko LA; Khrichkova TY; Simanina EV; Stavrova LA; Artamonov AV; Bekarev AA; Kinsht DN; Chaikovskiy AV; Markova TS; Gurto RV
Bull Exp Biol Med; 2011 Nov; 152(1):133-7. PubMed ID: 22803059
[TBL] [Abstract][Full Text] [Related]
38. Experimental study of ultralow-dose antibodies to cyclophosphamide on cyclophosphamide myelotoxicity.
Epstein OI; Dygai AM; Sergeeva SA; Zhdanov VV; Khrichkova TY; Stavrova LA; Zyuz'kov GN; Udut EV; Simanina EV
Bull Exp Biol Med; 2009 Mar; 147(3):323-7. PubMed ID: 19529853
[TBL] [Abstract][Full Text] [Related]
39. Comparison of the effects of 5-fluorouracil and Ftorafur on the haematopoiesis in mice.
Hrsak I; Pavicić S
Biomedicine; 1974 Apr; 21(4):164-7. PubMed ID: 4441584
[No Abstract] [Full Text] [Related]
40. Reactions of granulocytic lineage of hemopoiesis and mechanisms of their development in combined treatment with adriablastin and taxotere.
Gol'dberg VE; Khrichkova TY; Shatalova VA; Popova NO; Burshtein ES; Minakova MY; Zhdanov VV; Dygai AM
Bull Exp Biol Med; 2011 Apr; 150(6):718-24. PubMed ID: 22235426
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
